IFNG and type 2 diabetes mellitus: There were no significant differences in the substantial number of IFN-γ-secreting splenocytes induced by the CoVaccine HT-adjuvanted vaccine between the control, T1D, T2D, and OB models (Figure 3A), suggesting that an adjuvant may induce a more Th1 balanced immunity regardless of metabolic state.